News
ImmPACT Bio Announces Completion of Merger with Kalthera to Progress Next-Generation CAR T Therapies for the Treatment of Cancer
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Extension Of Innovation Partnering Office at Monash University In Collaboration With Victorian State Government To Accelerate The Life-Sciences Hub
Read full storyOther news
Ribon Therapeutics Secures $65 Million Financing
Read full storyOther news
Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
Read full storyOther news
POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company
Read full storyIn the media
Johnson & Johnson: The Leading Healthcare Group at the Forefront of Open Innovation
Read full storyOther news
TRexBio Closes the Final Tranche of $59 Million Series A Financing to Advance Innovation in Tissue Immunobiology for the treatment of Cancer and Inflammatory Diseases
Read full storyOther news
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Read full storyPartner news
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Read full storyIn the media
Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland
Read full storyOther news
Datavant and Ciox Health Announce Merger, Creating the Largest Neutral and Secure Health Data Ecosystem
Read full storyOther news
entrinsic bioscience Secures $49 million in Financing to Accelerate Development and Commercialization of Next Generation Functional Ingredients and Active Pharmaceutical Ingredients
Read full storyOther news
Thirty Madison Raises $140 Million in Series C Financing Led by HealthQuest Capital
Read full storyOther news